Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pyrroloquinoline quinone (PQQ) disodium salt is a redox-active cofactor and nutraceutical ingredient developed and manufactured by Fujian Comhony Biotechnology. As a small molecule, PQQ serves as a potent antioxidant and a key regulator of cellular energy metabolism. Its primary biological role involves the stimulation of mitochondrial biogenesis, largely through the activation of the peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) signaling pathway. By enhancing the production and function of mitochondria, PQQ is marketed for its potential benefits in supporting cognitive health, cardiovascular function, and overall cellular longevity. It is commonly utilized as a bulk ingredient in the formulation of dietary supplements.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pyrroloquinoline quinone disodium salt.